Skip to main content

Table 4 Disease activity and DAS28 scores and remission rates in the 2-year follow-up period

From: Association between pain phenotype and disease activity in rheumatoid arthritis patients: a non-interventional, longitudinal cohort study

 

Nociceptive pain phenotype

Non-nociceptive pain phenotype

OR (95% CI)

p

DAS28, mean (SD)

2.14 (0.85)

2.55 (0.87)

1.74 (1.21–2.50)

0.002

DAS28 categories, n (%)

  

1.44 (0.76–2.72)

0.062

 Remission/low disease activity

95 (88.0)

55 (77.5)

  

 Moderate/high disease activity

13 (11.9)

16 (22.5)

  

Remission achieved, n (%)

 SSR

79 (72.5)

39 (54.9)

0.49 (0.26–0.92)

0.020

 MSR

67 (61.5)

32 (45.1)

0.51 (0.28–0.94)

0.032

 LSR

63 (57.8)

26 (36.6)

0.42 (0.23–0.78)

0.006

  1. SSR short sustained remission (6–9 months), MSR medium sustained remission (9–12 months), LSR long sustained remission (≥12 months)